Changes in Ultrasonographic Assessment of Inflammation Upon Initiation of Adalimumab Combination Therapy in Chinese Rheumatoid Arthritis (RA) Patients With Inadequate Response to Methotrexate
Clinical trial NCT02786563 · WITHDRAWN
Trial details
- NCT number
- NCT02786563
- Sponsor
- AbbVie
- Status
- WITHDRAWN
- Study type
- OBSERVATIONAL
- Start date
- 2018-09-30
- Primary completion
- 2018-11-21
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.